[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Androgen Suppression Therapy Market Growth (Status and Outlook) 2024-2030

May 2024 | 104 pages | ID: G27ACD5CEE67EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Androgen suppression therapy (ADT), also known as hormone therapy, is a medical treatment that lowers the levels of male hormones, called androgens (primarily testosterone). It's primarily used for treating prostate cancer and sometimes other conditions that are affected by androgens.

The global Androgen Suppression Therapy market size is projected to grow from US$ 10500 million in 2023 to US$ 15160 million in 2030; it is expected to grow at a CAGR of 5.4% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Androgen Suppression Therapy Industry Forecast” looks at past sales and reviews total world Androgen Suppression Therapy sales in 2023, providing a comprehensive analysis by region and market sector of projected Androgen Suppression Therapy sales for 2024 through 2030. With Androgen Suppression Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Androgen Suppression Therapy industry.

This Insight Report provides a comprehensive analysis of the global Androgen Suppression Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Androgen Suppression Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Androgen Suppression Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Androgen Suppression Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Androgen Suppression Therapy.

The Androgen Suppression Therapy (ADT) market is expected to see steady growth in the coming years, driven by several key factors:

Market Drivers:

Rising incidence of prostate cancer: Prostate cancer is the most common cancer among men worldwide, and Androgen Suppression Therapy remains a cornerstone treatment option, fueling market demand.

Aging population: With an increasing aging population, the prevalence of prostate cancer and other conditions treated with Androgen Suppression Therapy is expected to rise, further propelling market growth.

Evolving treatment protocols: Advancements in medical research are leading to new and personalized approaches to Androgen Suppression Therapy, including shorter treatment durations and combination therapies, expanding market options.

Increasing awareness and access to treatment: Growing awareness about prostate cancer and its treatment options, coupled with improved healthcare access in some regions, is driving higher uptake of Androgen Suppression Therapy.

Development of novel formulations and delivery systems: Advancements in drug delivery, like long-acting injectable medications and oral medications with fewer side effects, are improving patient compliance and potentially expanding the market reach.

Challenges and Future Outlook:

Cost-effectiveness concerns: Androgen Suppression Therapy can be expensive, and rising healthcare costs could limit accessibility for patients in some regions.

Side effects and long-term health impacts: The potential side effects of Androgen Suppression Therapy, including bone loss and cardiovascular risks, require ongoing research and development of safer and more effective treatment options.

Patient compliance: Addressing concerns about side effects and ensuring adherence to treatment protocols remain crucial for achieving optimal treatment outcomes.

Despite these challenges, the Androgen Suppression Therapy market holds promising potential for sustained growth. Continued research into novel therapies, improved access to treatment, and developing personalized treatment plans will be key factors in shaping the future of this market.

This report presents a comprehensive overview, market shares, and growth opportunities of Androgen Suppression Therapy market by product type, application, key players and key regions and countries.

Segmentation by type
  • Tablet
  • Injection
Segmentation by application
  • Hospital
  • Clinic
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Pfizer
  • Astellas
  • Johnson & Johnson
  • AstraZeneca
  • Bayer
  • Merck
  • Tolmar
  • Zoladex
  • Ferring Pharmaceuticals
  • Jiangsu Hengrui Pharmaceuticals
  • CTTQ
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Androgen Suppression Therapy Market Size 2019-2030
  2.1.2 Androgen Suppression Therapy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Androgen Suppression Therapy Segment by Type
  2.2.1 Tablet
  2.2.2 Injection
2.3 Androgen Suppression Therapy Market Size by Type
  2.3.1 Androgen Suppression Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Androgen Suppression Therapy Market Size Market Share by Type (2019-2024)
2.4 Androgen Suppression Therapy Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Others
2.5 Androgen Suppression Therapy Market Size by Application
  2.5.1 Androgen Suppression Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Androgen Suppression Therapy Market Size Market Share by Application (2019-2024)

3 ANDROGEN SUPPRESSION THERAPY MARKET SIZE BY PLAYER

3.1 Androgen Suppression Therapy Market Size Market Share by Players
  3.1.1 Global Androgen Suppression Therapy Revenue by Players (2019-2024)
  3.1.2 Global Androgen Suppression Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Androgen Suppression Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ANDROGEN SUPPRESSION THERAPY BY REGIONS

4.1 Androgen Suppression Therapy Market Size by Regions (2019-2024)
4.2 Americas Androgen Suppression Therapy Market Size Growth (2019-2024)
4.3 APAC Androgen Suppression Therapy Market Size Growth (2019-2024)
4.4 Europe Androgen Suppression Therapy Market Size Growth (2019-2024)
4.5 Middle East & Africa Androgen Suppression Therapy Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Androgen Suppression Therapy Market Size by Country (2019-2024)
5.2 Americas Androgen Suppression Therapy Market Size by Type (2019-2024)
5.3 Americas Androgen Suppression Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Androgen Suppression Therapy Market Size by Region (2019-2024)
6.2 APAC Androgen Suppression Therapy Market Size by Type (2019-2024)
6.3 APAC Androgen Suppression Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Androgen Suppression Therapy by Country (2019-2024)
7.2 Europe Androgen Suppression Therapy Market Size by Type (2019-2024)
7.3 Europe Androgen Suppression Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Androgen Suppression Therapy by Region (2019-2024)
8.2 Middle East & Africa Androgen Suppression Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Androgen Suppression Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ANDROGEN SUPPRESSION THERAPY MARKET FORECAST

10.1 Global Androgen Suppression Therapy Forecast by Regions (2025-2030)
  10.1.1 Global Androgen Suppression Therapy Forecast by Regions (2025-2030)
  10.1.2 Americas Androgen Suppression Therapy Forecast
  10.1.3 APAC Androgen Suppression Therapy Forecast
  10.1.4 Europe Androgen Suppression Therapy Forecast
  10.1.5 Middle East & Africa Androgen Suppression Therapy Forecast
10.2 Americas Androgen Suppression Therapy Forecast by Country (2025-2030)
  10.2.1 United States Androgen Suppression Therapy Market Forecast
  10.2.2 Canada Androgen Suppression Therapy Market Forecast
  10.2.3 Mexico Androgen Suppression Therapy Market Forecast
  10.2.4 Brazil Androgen Suppression Therapy Market Forecast
10.3 APAC Androgen Suppression Therapy Forecast by Region (2025-2030)
  10.3.1 China Androgen Suppression Therapy Market Forecast
  10.3.2 Japan Androgen Suppression Therapy Market Forecast
  10.3.3 Korea Androgen Suppression Therapy Market Forecast
  10.3.4 Southeast Asia Androgen Suppression Therapy Market Forecast
  10.3.5 India Androgen Suppression Therapy Market Forecast
  10.3.6 Australia Androgen Suppression Therapy Market Forecast
10.4 Europe Androgen Suppression Therapy Forecast by Country (2025-2030)
  10.4.1 Germany Androgen Suppression Therapy Market Forecast
  10.4.2 France Androgen Suppression Therapy Market Forecast
  10.4.3 UK Androgen Suppression Therapy Market Forecast
  10.4.4 Italy Androgen Suppression Therapy Market Forecast
  10.4.5 Russia Androgen Suppression Therapy Market Forecast
10.5 Middle East & Africa Androgen Suppression Therapy Forecast by Region (2025-2030)
  10.5.1 Egypt Androgen Suppression Therapy Market Forecast
  10.5.2 South Africa Androgen Suppression Therapy Market Forecast
  10.5.3 Israel Androgen Suppression Therapy Market Forecast
  10.5.4 Turkey Androgen Suppression Therapy Market Forecast
  10.5.5 GCC Countries Androgen Suppression Therapy Market Forecast
10.6 Global Androgen Suppression Therapy Forecast by Type (2025-2030)
10.7 Global Androgen Suppression Therapy Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Androgen Suppression Therapy Product Offered
  11.1.3 Pfizer Androgen Suppression Therapy Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 Astellas
  11.2.1 Astellas Company Information
  11.2.2 Astellas Androgen Suppression Therapy Product Offered
  11.2.3 Astellas Androgen Suppression Therapy Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Astellas Main Business Overview
  11.2.5 Astellas Latest Developments
11.3 Johnson & Johnson
  11.3.1 Johnson & Johnson Company Information
  11.3.2 Johnson & Johnson Androgen Suppression Therapy Product Offered
  11.3.3 Johnson & Johnson Androgen Suppression Therapy Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Johnson & Johnson Main Business Overview
  11.3.5 Johnson & Johnson Latest Developments
11.4 AstraZeneca
  11.4.1 AstraZeneca Company Information
  11.4.2 AstraZeneca Androgen Suppression Therapy Product Offered
  11.4.3 AstraZeneca Androgen Suppression Therapy Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 AstraZeneca Main Business Overview
  11.4.5 AstraZeneca Latest Developments
11.5 Bayer
  11.5.1 Bayer Company Information
  11.5.2 Bayer Androgen Suppression Therapy Product Offered
  11.5.3 Bayer Androgen Suppression Therapy Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Bayer Main Business Overview
  11.5.5 Bayer Latest Developments
11.6 Merck
  11.6.1 Merck Company Information
  11.6.2 Merck Androgen Suppression Therapy Product Offered
  11.6.3 Merck Androgen Suppression Therapy Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Merck Main Business Overview
  11.6.5 Merck Latest Developments
11.7 Tolmar
  11.7.1 Tolmar Company Information
  11.7.2 Tolmar Androgen Suppression Therapy Product Offered
  11.7.3 Tolmar Androgen Suppression Therapy Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Tolmar Main Business Overview
  11.7.5 Tolmar Latest Developments
11.8 Zoladex
  11.8.1 Zoladex Company Information
  11.8.2 Zoladex Androgen Suppression Therapy Product Offered
  11.8.3 Zoladex Androgen Suppression Therapy Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Zoladex Main Business Overview
  11.8.5 Zoladex Latest Developments
11.9 Ferring Pharmaceuticals
  11.9.1 Ferring Pharmaceuticals Company Information
  11.9.2 Ferring Pharmaceuticals Androgen Suppression Therapy Product Offered
  11.9.3 Ferring Pharmaceuticals Androgen Suppression Therapy Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Ferring Pharmaceuticals Main Business Overview
  11.9.5 Ferring Pharmaceuticals Latest Developments
11.10 Jiangsu Hengrui Pharmaceuticals
  11.10.1 Jiangsu Hengrui Pharmaceuticals Company Information
  11.10.2 Jiangsu Hengrui Pharmaceuticals Androgen Suppression Therapy Product Offered
  11.10.3 Jiangsu Hengrui Pharmaceuticals Androgen Suppression Therapy Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Jiangsu Hengrui Pharmaceuticals Main Business Overview
  11.10.5 Jiangsu Hengrui Pharmaceuticals Latest Developments
11.11 CTTQ
  11.11.1 CTTQ Company Information
  11.11.2 CTTQ Androgen Suppression Therapy Product Offered
  11.11.3 CTTQ Androgen Suppression Therapy Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 CTTQ Main Business Overview
  11.11.5 CTTQ Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Androgen Suppression Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Tablet
Table 3. Major Players of Injection
Table 4. Androgen Suppression Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Androgen Suppression Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Androgen Suppression Therapy Market Size Market Share by Type (2019-2024)
Table 7. Androgen Suppression Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Androgen Suppression Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Androgen Suppression Therapy Market Size Market Share by Application (2019-2024)
Table 10. Global Androgen Suppression Therapy Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Androgen Suppression Therapy Revenue Market Share by Player (2019-2024)
Table 12. Androgen Suppression Therapy Key Players Head office and Products Offered
Table 13. Androgen Suppression Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Androgen Suppression Therapy Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Androgen Suppression Therapy Market Size Market Share by Regions (2019-2024)
Table 18. Global Androgen Suppression Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Androgen Suppression Therapy Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Androgen Suppression Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Androgen Suppression Therapy Market Size Market Share by Country (2019-2024)
Table 22. Americas Androgen Suppression Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Androgen Suppression Therapy Market Size Market Share by Type (2019-2024)
Table 24. Americas Androgen Suppression Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Androgen Suppression Therapy Market Size Market Share by Application (2019-2024)
Table 26. APAC Androgen Suppression Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Androgen Suppression Therapy Market Size Market Share by Region (2019-2024)
Table 28. APAC Androgen Suppression Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Androgen Suppression Therapy Market Size Market Share by Type (2019-2024)
Table 30. APAC Androgen Suppression Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Androgen Suppression Therapy Market Size Market Share by Application (2019-2024)
Table 32. Europe Androgen Suppression Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Androgen Suppression Therapy Market Size Market Share by Country (2019-2024)
Table 34. Europe Androgen Suppression Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Androgen Suppression Therapy Market Size Market Share by Type (2019-2024)
Table 36. Europe Androgen Suppression Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Androgen Suppression Therapy Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Androgen Suppression Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Androgen Suppression Therapy Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Androgen Suppression Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Androgen Suppression Therapy Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Androgen Suppression Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Androgen Suppression Therapy Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Androgen Suppression Therapy
Table 45. Key Market Challenges & Risks of Androgen Suppression Therapy
Table 46. Key Industry Trends of Androgen Suppression Therapy
Table 47. Global Androgen Suppression Therapy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Androgen Suppression Therapy Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Androgen Suppression Therapy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Androgen Suppression Therapy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Pfizer Details, Company Type, Androgen Suppression Therapy Area Served and Its Competitors
Table 52. Pfizer Androgen Suppression Therapy Product Offered
Table 53. Pfizer Androgen Suppression Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Pfizer Main Business
Table 55. Pfizer Latest Developments
Table 56. Astellas Details, Company Type, Androgen Suppression Therapy Area Served and Its Competitors
Table 57. Astellas Androgen Suppression Therapy Product Offered
Table 58. Astellas Main Business
Table 59. Astellas Androgen Suppression Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Astellas Latest Developments
Table 61. Johnson & Johnson Details, Company Type, Androgen Suppression Therapy Area Served and Its Competitors
Table 62. Johnson & Johnson Androgen Suppression Therapy Product Offered
Table 63. Johnson & Johnson Main Business
Table 64. Johnson & Johnson Androgen Suppression Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Johnson & Johnson Latest Developments
Table 66. AstraZeneca Details, Company Type, Androgen Suppression Therapy Area Served and Its Competitors
Table 67. AstraZeneca Androgen Suppression Therapy Product Offered
Table 68. AstraZeneca Main Business
Table 69. AstraZeneca Androgen Suppression Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. AstraZeneca Latest Developments
Table 71. Bayer Details, Company Type, Androgen Suppression Therapy Area Served and Its Competitors
Table 72. Bayer Androgen Suppression Therapy Product Offered
Table 73. Bayer Main Business
Table 74. Bayer Androgen Suppression Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Bayer Latest Developments
Table 76. Merck Details, Company Type, Androgen Suppression Therapy Area Served and Its Competitors
Table 77. Merck Androgen Suppression Therapy Product Offered
Table 78. Merck Main Business
Table 79. Merck Androgen Suppression Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Merck Latest Developments
Table 81. Tolmar Details, Company Type, Androgen Suppression Therapy Area Served and Its Competitors
Table 82. Tolmar Androgen Suppression Therapy Product Offered
Table 83. Tolmar Main Business
Table 84. Tolmar Androgen Suppression Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Tolmar Latest Developments
Table 86. Zoladex Details, Company Type, Androgen Suppression Therapy Area Served and Its Competitors
Table 87. Zoladex Androgen Suppression Therapy Product Offered
Table 88. Zoladex Main Business
Table 89. Zoladex Androgen Suppression Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Zoladex Latest Developments
Table 91. Ferring Pharmaceuticals Details, Company Type, Androgen Suppression Therapy Area Served and Its Competitors
Table 92. Ferring Pharmaceuticals Androgen Suppression Therapy Product Offered
Table 93. Ferring Pharmaceuticals Main Business
Table 94. Ferring Pharmaceuticals Androgen Suppression Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Ferring Pharmaceuticals Latest Developments
Table 96. Jiangsu Hengrui Pharmaceuticals Details, Company Type, Androgen Suppression Therapy Area Served and Its Competitors
Table 97. Jiangsu Hengrui Pharmaceuticals Androgen Suppression Therapy Product Offered
Table 98. Jiangsu Hengrui Pharmaceuticals Main Business
Table 99. Jiangsu Hengrui Pharmaceuticals Androgen Suppression Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Jiangsu Hengrui Pharmaceuticals Latest Developments
Table 101. CTTQ Details, Company Type, Androgen Suppression Therapy Area Served and Its Competitors
Table 102. CTTQ Androgen Suppression Therapy Product Offered
Table 103. CTTQ Androgen Suppression Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. CTTQ Main Business
Table 105. CTTQ Latest Developments

LIST OF FIGURES

Figure 1. Androgen Suppression Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Androgen Suppression Therapy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Androgen Suppression Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Androgen Suppression Therapy Sales Market Share by Country/Region (2023)
Figure 8. Androgen Suppression Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Androgen Suppression Therapy Market Size Market Share by Type in 2023
Figure 10. Androgen Suppression Therapy in Hospital
Figure 11. Global Androgen Suppression Therapy Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Androgen Suppression Therapy in Clinic
Figure 13. Global Androgen Suppression Therapy Market: Clinic (2019-2024) & ($ Millions)
Figure 14. Androgen Suppression Therapy in Others
Figure 15. Global Androgen Suppression Therapy Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Androgen Suppression Therapy Market Size Market Share by Application in 2023
Figure 17. Global Androgen Suppression Therapy Revenue Market Share by Player in 2023
Figure 18. Global Androgen Suppression Therapy Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Androgen Suppression Therapy Market Size 2019-2024 ($ Millions)
Figure 20. APAC Androgen Suppression Therapy Market Size 2019-2024 ($ Millions)
Figure 21. Europe Androgen Suppression Therapy Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Androgen Suppression Therapy Market Size 2019-2024 ($ Millions)
Figure 23. Americas Androgen Suppression Therapy Value Market Share by Country in 2023
Figure 24. United States Androgen Suppression Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Androgen Suppression Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Androgen Suppression Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Androgen Suppression Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Androgen Suppression Therapy Market Size Market Share by Region in 2023
Figure 29. APAC Androgen Suppression Therapy Market Size Market Share by Type in 2023
Figure 30. APAC Androgen Suppression Therapy Market Size Market Share by Application in 2023
Figure 31. China Androgen Suppression Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Androgen Suppression Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Androgen Suppression Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Androgen Suppression Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Androgen Suppression Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Androgen Suppression Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Androgen Suppression Therapy Market Size Market Share by Country in 2023
Figure 38. Europe Androgen Suppression Therapy Market Size Market Share by Type (2019-2024)
Figure 39. Europe Androgen Suppression Therapy Market Size Market Share by Application (2019-2024)
Figure 40. Germany Androgen Suppression Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Androgen Suppression Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Androgen Suppression Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Androgen Suppression Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Androgen Suppression Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Androgen Suppression Therapy Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Androgen Suppression Therapy Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Androgen Suppression Therapy Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Androgen Suppression Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Androgen Suppression Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Androgen Suppression Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Androgen Suppression Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Androgen Suppression Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 54. APAC Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 55. Europe Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 57. United States Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 58. Canada Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 61. China Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 62. Japan Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 63. Korea Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 65. India Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 66. Australia Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 67. Germany Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 68. France Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 69. UK Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 70. Italy Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 71. Russia Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 72. Spain Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 75. Israel Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Androgen Suppression Therapy Market Size 2025-2030 ($ Millions)
Figure 78. Global Androgen Suppression Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Androgen Suppression Therapy Market Size Market Share Forecast by Application (2025-2030)


More Publications